Vaccines

The U.S. Food and Drug Administration is looking to grant full approval to the Pfizer Inc. (NYSE: PFE)-BioNTech SE (NASDAQ: BNTX) COVID-19 vaccine by early September, the New York Times reported Tuesday, citing people involved in the effort. What Happened: The FDA is looking at a full approval of...

Vaxart Inc. (NASDAQ: VXRT) shares pushed higher Monday after the company made an announcement stating the U.S. Food and Drug Administration cleared its Investigational New Drug application for an S-only oral tablet SARS-CoV-2 vaccine candidate. Vaxart was up 11.13% at $7.99 at last check...

Moderna Inc. (NASDAQ: MRNA) has joined AMC Entertainment Holdings Inc. (NYSE: AMC) and Nvidia Corp. (NASDAQ: NVDA) as the stocks seeing high interest on Reddit’s r/WallStreetBets forum, even as SPDR S&P 500 ETF Trust (NYSE: SPY) remained the most-discussed stock on the forum, as of...

Shares of Johnson & Johnson (NYSE: JNJ) rose 0.7% in the regular trading session on Thursday and were trading slightly higher in the market session on Friday. What Happened: Johnson & Jonson said late Thursday that its single-shot COVID-19 vaccine showed strong promise against the fast-...

CNBC host Jim Cramer believes biotechnology company Moderna Inc. (NASDAQ: MRNA) is an “excellent company and stock” that has a reach far beyond COVID-19.   What Happened: Cramer made the comments on Twitter. let me just say, though, i think Moderna will do far more than covid and...

Shares of COVID-19 vaccine companies Moderna Inc (NASDAQ: MRNA), Pfizer Inc. (NYSE: PFE) and BioNTech SE - ADR (NASDAQ: BNTX) are moving sharply lower Wednesday. What Happened: Administering of mRNA vaccines, the class of vaccines developed by Moderna and Pfizer-BioNTech, resulted in...

The Pfizer Inc (NYSE: PFE)/BioNTech SE (NASDAQ: BNTX) COVID-19 vaccine has received provisional approval for use in the age group 12 to 15 from New Zealand's medical regulator, Stuff reported Monday (local time). What Happened: The vaccine already stands approved for those 16 years...

CureVac N.V.’s (NASDAQ: CVAC) Chief Financial Officer Pierre Kemula is optimistic its COVID-19 vaccine could still be offered to certain age groups or as a booster, the Financial Times reported on Thursday. What Happened: Kemula told FT the German vaccine developer is still hopeful the...

Novavax Inc (NASDAQ: NVAX) COVID-19 vaccine, marketed as "Covovax," could see a launch in India as early as September, Moneycontrol reported on Wednesday. What Happened: Covovax trials have reached an advanced stage of completion in India following which the U.S.-based...

Pfizer Inc. (NYSE: PFE) and its German partner BioNTech SE (Nasdaq: BNTX) said they plan to provide 500 million doses of their COVID-19 vaccine to the U.S. government for donation to the "poorest nations." What Happened: The two companies said they will provide the 500 million doses of...

Shares of Ocugen Inc. (NASDAQ: OCGN), India-based Bharat Biotech’s U.S. partner for COVID-19 vaccine Covaxin, fell 3.7% in Wednesday’s regular trading session. What Happened: Ocugen said late Wednesday it plans to submit an Emergency Use Authorization (EUA) application for Covaxin to...

The U.S. Food and Drug Administration on Monday approved the emergency use of Pfizer Inc. (NYSE: PFE) and BioNTech SE’s (NASDAQ: BNTX) COVID-19 vaccine in adolescents aged between 12 to 15 years. What Happened: The FDA said it has amended the emergency use authorization (EUA) originally...

Shares of biotechnology company Moderna Inc. (NASDAQ: MRNA) fell more than 6% in Wednesday’s regular trading session, but rebounded more than 1% in the extended session. What Happened: The after-hours surge came as Moderna reported the effectiveness of its COVID-19 vaccine against variants in...

The Food and Drug Administration has plans to authorize the emergency use of Pfizer Inc (NYSE: PFE) and BioNTech SE's (NASDAQ: BNTX) jointly-developed COVID-19 vaccine in adolescents aged between 12 to 15 years, the New York Times reported Monday. What Happened: The move means that...

The week of May 3 has several IPOs on the docket spread across sectors like consumer products, fashion, banking, vaccines and hydroponics. Here is a look at this week’s top offerings and details investors should know. Waterdrop: Working with insurance companies, Waterdrop (NYSE: WDH) seeks to...